Sunday, February 28, 2016

Valeant Says CEO Michael Pearson Returning

Valeant Pharmaceuticals said chief executive Michael Pearson has returned from medical leave to lead the company, and the embattled Canadian drugmaker moved to split its chief executive and chairman roles.

from WSJ.com: US Business http://ift.tt/1pjg2pQ
via IFTTT

No comments:

Post a Comment